WeVote
Log In

Bill

Bill

S 6034

Requires public hospitals to establish auto-immune disease treatment centers

2025 Regular Session Introduced by Kevin Parker

Public hospitals would be required to set up autoimmune disease treatment centers, expanding access to specialized care but requiring funding, staffing, and oversight.

REFERRED TO HEALTH
0
WeVote Research Nonpartisan
Bill Summary · S 6034

Summary of Bill S 6034: Requires public hospitals to establish auto-immune disease treatment centers

Overview

  • Bill Number: S 6034
  • Title: Requires public hospitals to establish auto-immune disease treatment centers
  • Status: REFERRED TO HEALTH
  • Introduced: March 5, 2025
  • Classification: Bill
  • Related bills: S 7762 (prior-session), A 5118 (companion) – A 5118 listed twice as companions in related references

What is known from the provided information

  • Core purpose: The bill would require public hospitals to establish specialized treatment centers focused on autoimmune diseases.
  • Legislative progress: The measure was introduced on March 5, 2025 and referred to the Health committee. No further actions or timelines are provided in the supplied information.

Key provisions (as currently available)

  • Known provision:
    • Public hospitals would be required to establish auto-immune disease treatment centers.
  • Not specified in the provided text (to be confirmed with the full bill):
    • Definitions (e.g., what counts as a “public hospital” and what constitutes an “auto-immune disease treatment center”).
    • Scope of services to be offered (clinical care, diagnostics, research, patient education, outreach).
    • Funding sources and total cost, including initial capital, operating expenses, and ongoing support.
    • Staffing requirements (specialty physicians, nurses, allied health professionals, administrative staff).
    • Standards, accreditation, and quality metrics for the centers.
    • Geographic coverage and integration with existing hospital and public health systems.
    • Reporting, oversight, and accountability measures (e.g., annual reports, performance benchmarks).
    • Implementation timeline or phase-in schedule.
    • Compliance requirements and penalties for non-compliance.
    • Patient eligibility, access considerations, and potential impact on existing services.

Potential impacts and considerations

  • Health system impact: If enacted, public hospitals would need to create dedicated autoimmune disease treatment centers, with associated budgeting, staffing, and operational changes. This could improve access to specialized care for patients with autoimmune conditions.
  • Budgetary considerations: The bill’s fiscal implications (costs, funding mechanisms, and potential savings from improved management of autoimmune diseases) would depend on the full text and any enacted appropriations.
  • Equity and access: Aimed at expanding specialized care within public hospitals, potentially improving care availability for underserved populations.
  • Implementation risk: Success would hinge on clear definitions, adequate funding, and realistic timelines, as well as coordination with state health authorities and existing hospital infrastructure.

Related legislation

  • S 7762 (prior-session) may contain similar or related provisions.
  • A 5118 (companion) exists, indicating cross-chamber interest in establishing autoimmune treatment centers.

Next steps for readers

  • Obtain the full bill text to review precise definitions, requirements, funding, and timelines.
  • Monitor Health Committee actions for hearings, amendments, and votes.
  • Review companion and related bills (S 7762, A 5118) for parallel provisions or negotiated language.
  • Consider potential fiscal notes and impact analyses once released.

If you’d like, I can incorporate the full text when it becomes available and provide a detailed, provision-by-provision analysis.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.